Experimental assessment of immunobiological activity of the roncoleukine immunomodulatory agent


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

We have found that roncoleukine (recombinant interleukin 2, rIL-2) when double administered in the dose of 5000 IU/kg of body weight or 10000 IU/kg of body weight enhanced functional activity of the effector cells of the delayed type hypersensitivity. It was demonstrated that the selective action of rIL-2 in the dose of 10000 IU/kg of body weight induced protective effect (more than 50%) in the mice experimentally infected with T. spiralis.

About the authors

O. I. Mamykova

Skryabin All-Russia Research Institute of Fundamental and Applied Parasitology of Animals and Plants

Author for correspondence.
Email: olgamamykova@yandex.ru
Russian Federation, Moscow, 117218

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2016 Allerton Press, Inc.